Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Adverse Effects Uncommon Following Colonoscopy

By HospiMedica International staff writers
Posted on 20 Mar 2013
A new study provides further evidence on the safety of both screening and nonscreening colonoscopies in routine practice.

Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany) evaluated data of over 30,000 individuals insured with the German statutory health insurance (AOK) who had undergone outpatient colonoscopy between 2001 and 2008; a control group consisted of insured persons who had not had a screening test. More...
The researchers analyzed the incidence of serious adverse events (AEs) such as intestinal wall injuries, intestinal or splenic bleeding, myocardial infarction (MI), stroke, and overall mortality. The period for evaluation included 30 days following the colonoscopy in order to include possible late effects.

The results showed that the incidence of perforation was 0.8 per 1,000 screening and nonscreening colonoscopies. Hospitalizations because of bleeding occurred in 0.5 per 1,000 screening and nonscreening colonoscopies. The incidence of MI, stroke, and other nongastrointestinal AEs was similar in colonoscopy and control groups; no splenic injury was observed. Participants with AEs generally had a higher mean age and comorbidity rate than the overall study population. The study was published in the March 2013 issue of Gastrointestinal Endoscopy.

“For an examination offered to large portions of the population, the question of safety is of central importance. Therefore, it is equally important that physicians and public health experts are very well informed about the risks of complications,” said senior author Prof. Hermann Brenner, MD. “Only then can they profoundly evaluate chances and risks of a colonoscopy with their patients.”

Colon cancer is the second most common cancer in in Germany and the second most common cause of cancer-related death. Approximately 65,000 people are newly diagnosed with colorectal cancer every year and 26,000 people succumbed to the disease in 2010. Since 2002, colonoscopy is part of the national statutory cancer screening program in Germany for all insured persons aged 55 or older, but only one fifth of those eligible actually make use of the screening program. The reasons for this are manifold, including fear of a frightening diagnosis and of a potentially unpleasant examination, which can also lead to complications.

Related Links:

German Cancer Research Center




Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.